Amid fluctuating tariffs and complex trade policies, healthcare and life sciences (HLS) companies face mounting operational and legal challenges within their global supply chains. Organizations are taking steps to retool their supply chains in response to threats against stability, but change introduces myriad knock-on implications. In the second article of the series, we explore four key questions for HLS businesses considering new supply chain strategies:
The healthcare and life sciences sector is facing new trade winds and a looming threat of increased tariffs. This places additional pressure on a typical life sciences supply chain timeline. We recently launched a four-part article series on supply chains, aimed at exploring the legal and operational complexities that healthcare and life sciences companies face as they navigate evolving global supply chain challenges. The first article explores the steps companies can take to ensure business continuity in…
Today, companies must navigate intertwining ESG compliance requirements in their supply chains spanning across: – Supply chain transparency and due diligence requirements – Trade and import bans – Investigation and litigation risks, and – Reputational and brand risks In the latest webinar as part of our “2022 International Supply Chain Series”, Kerry Contini (Partner, Washington DC) , Nicolai Behr (Partner, Munich) Kevin Coon (Partner, Toronto), Reagan Demas (Partner, Washington DC), Sean Selleck (Partner, Melbourne) and…
On December 23, 2022, President Biden signed into law the National Defense Authorization Act for Fiscal Year 2023 (âFY2023 NDAAâ). Section 5949 of FY2023 NDAA (âSection 5949â) would prohibit executive agencies from procuring or contracting with entities to obtain any electronic parts, products, or services that include covered semiconductor products or services from certain Chinese companies. The semiconductor prohibitions will not take effect until five years after the date of enactment, and the Federal Acquisition…
On June 23, 2022, the US Department of Health and Human Services (“HHS”) Office on Trafficking in Persons (“OTIP”) issued a request for information (“RFI”) on forced labor, a form of human trafficking, in healthcare supply chains. This RFI is part of OTIPâs ongoing efforts to seek public comments to inform implementation of Executive Order 14001 “A Sustainable Public Health Supply Chain”, the National Strategy for a Resilient Public Health Supply Chain, and other related…
On February 24, 2022, various U.S. government agencies published their respective reports on supply chain policies for six key industrial bases pursuant to Executive Order 14017, âAmericaâs Supply Chainsâ (the âReportsâ). These Reports identify key weaknesses in some of the nationâs most crucial supply chains and offer multi-year strategies to help address those weaknesses. The White House issued this statement and capstone report following the publication of the Reports. Links to the Reports and corresponding…
On January 26, 2022, the US Departments of State, Treasury, Commerce, Labor, Homeland Security and the Office of the US Trade Representative (âUSTRâ) issued a joint advisory (the âAdvisoryâ) that highlights certain supply chain-related risks for companies whose business and supply chains may touch Burma/Myanmar. This is a continuation of a recent trend in which the US Government has issued advisories highlighting compliance and related risks in certain countries and regions, often emphasizing supply chain risks. For…
Baker McKenzie is pleased to launch the fifth in our Biden Supply Chain Policy video series focused on the pharmaceuticals and active pharmaceutical ingredients supply chain, which is another of the critical supply chains that has been a particular focus of the Biden Administration. The Biden Administration has been pursuing policies aimed at increasing resilience in this supply chain by addressing shortages and minimizing disruption through a range of measures, including efforts to on-shore and near-shore…
Baker McKenzie is pleased to launch the fourth in our Biden Supply Chain Policy video series focused on the critical minerals and strategic materials supply chain, which is another of the critical supply chains that has been a particular focus of the Biden Administration. This supply chain includes lithium, cobalt and other rare earths and minerals that are the building blocks of products used every day. The Biden Administration has been pursuing policies aimed at…
Following our first two short videos on key trends (see here) and the semiconductor supply chain (see here), Baker McKenzie is pleased to launch the third in our Biden Supply Chain Policy video series focused on the large-capacity batteries supply chain. This is another of the critical supply chains that has been a particular focus of the Biden Administration’s supply chain policies. Large-capacity batteries are an important part of the energy transition. Demand for these batteries…